1. |
Douillard JY, Siena S, Cassidy J, et al. Randomized, phase Ⅲ trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer:the PRIME study[J]. J Clin Oncol, 2010, 28(31):4697-4705.
|
2. |
Peeters M, Price TJ, Cervantes A, et al. Randomized phase Ⅲ study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer[J]. J Clin Oncol, 2010, 28(31):4706-4713.
|
3. |
Hendlisz A, Van Den Eynde M, Peeters M, et al. Phase Ⅲ trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy[J]. J Clin Oncol, 2010, 28(23):3687-3694.
|
4. |
Tebbutt NC, Wilson K, Gebski VJ, et al. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer:results of the Australasian Gastrointestinal Trials Group Randomized Phase Ⅲ MAX Study[J]. J Clin Oncol, 2010, 28(19):3191-3198.
|
5. |
Khambata-Ford S, Harbison CT, Hart LL, et al. Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase Ⅲ study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(6):918-927.
|
6. |
陈俊霞, 俊夏, 刘基巍, 等. 人参皂甙Rg3诱导乳腺癌细胞系MCF-7凋亡的实验研究[J]. 癌变·畸变·突变, 2005, 17(4):213-216.
|
7. |
何芳, 曾文铤, 沈浩贤. 人参皂甙Rg3联合三氧化二砷对人肝癌裸鼠的治疗作用[J]. 中国误诊学杂志, 2007, 7(28):6757-6758.
|
8. |
孙燕, 林洪生, 朱允中, 等. 长春瑞滨合并顺铂(NP)加参一胶囊或安慰剂治疗晚期非小细胞肺癌的多中心双盲随机临床研究报告[J]. 中国肺癌杂志, 2006, 9(3):254-258.
|
9. |
Chen J, Peng H, Ou-Yang X, et al. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells[J]. Melanoma Res, 2008, 18(5):322-329.
|
10. |
Lee SY, Kim GT, Roh SH, et al. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines[J]. Biosci Biotechnol Biochem, 2009,73(4):811-816.
|
11. |
Wang CZ, Xie JT, Fishbein A, et al. Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells[J]. Phytother Res, 2009, 23(1):6-13.
|
12. |
Li B, Zhao J, Wang CZ, et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53[J]. Cancer Lett, 2011, 301(2):185-192.
|
13. |
Liu TG, Huang Y, Cui DD, et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice[J]. BMC Cancer, 2009, 9:250.
|
14. |
Xu TM, Xin Y, Cui MH, et al. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer[J]. Chin Med J, 2007, 120(7):584-588.
|
15. |
Kim SM, Lee SY, Yuk DY, et al. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel[J]. Arch Pharm Res, 2009, 32(5):755-765.
|